News, Short Squeeze, Breakout and More Instantly...
Cato Corporation Class A Company Name:
CATO Stock Symbol:
NYSE Market:
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
CATO REPORTS 4Q AND FULL YEAR LOSS PR Newswire CHARLOTTE, N.C. , March 21, 2024 /PRNewswire/ -- The Cato Corporation (NYSE: CATO) today reported a net loss of ($23.4) million or ($1.14) per diluted share for the fourth quarter ended February 3, 2024 ,...